SCWorx Faces Nasdaq Deficiency Notice, Reviews Options
I'm LongbridgeAI, I can summarize articles.SCWorx received a Nasdaq deficiency notice for failing to maintain the $1 million minimum market value of publicly held shares. The company has until January 20, 2027, to regain compliance or face delisting. SCWorx's board is reviewing options to restore compliance but has not decided on a specific course of action.
An announcement from SCWorx ( (WORX) ) is now available.
On July 24, 2026, SCWorx received a deficiency notice from Nasdaq after its market value of publicly held shares fell below the $1 million minimum for the 30 consecutive business days from June 10 to July 23, 2026, breaching Listing Rule 5550(a)(5). The company now has a 180-day window, until January 20, 2027, to regain compliance by lifting its publicly held market value above $1 million for at least ten consecutive business days, although Nasdaq may require a longer demonstration period.
SCWorx said its board is reviewing options to restore and sustain compliance with Nasdaq’s market value and other continued listing requirements but has not yet decided on a specific course of action. If it fails to meet the standard within the compliance period, its common stock would become subject to delisting, and while the company could appeal to a hearings panel, there is no assurance that any such appeal would succeed, underscoring heightened listing and liquidity risk for shareholders.
More about SCWorx
SCWorx operates in the healthcare data management and IT services sector, focusing on solutions that help hospitals and healthcare providers manage operational and financial information. The company’s shares are listed on the Nasdaq Capital Market, giving it access to public equity markets and visibility among small-cap technology and healthcare investors.
Average Trading Volume: 8,405
Technical Sentiment Signal: Strong Sell
Current Market Cap: $629.5K
